The 340B Rebate Model: Cash Flow, Claims Data, and Compliance Challenges
The 340B Drug Pricing Program helps eligible healthcare providers stretch limited resources to serve patients and communities in need. However, the proposed shift from upfront discounts to rebates for selected drugs could introduce new financial, technical, and compliance challenges for covered entities. Understanding the 340B Rebate Model Established in 1992, the 340B Program enables eligible […]
The 340B Rebate Model: Cash Flow, Claims Data, and Compliance Challenges Read More ยป
